David is Investment Director in the Korys life sciences team and manages the direct and fund investment activities. He also acts as an advisor for the OMX Europe Investment Fund. His ambition is to improve patients’ health by supporting young biotech companies. Before joining Korys in 2021, David was active in the venture capital and biotech space for more than 15 years. He studied the relationship between international venture capital investors and their portfolio companies in Europe and then joined PMV. At UCB he was the Head of the Immunology R&D Insights to Impact team. David holds a Master in Pharmaceutical Sciences and a Master in Economics and Business Administration from Ghent University, as well as a PhD in Entrepreneurial Finance from Vlerick Business School.
BioTech, HealthTech
📍 Based in Halle
Direct Professional Email Pattern
AI Outreach Agent Pitch Writer
Compose an personalized, high-converting outreach message targeting their exact investment interest...